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introduction
The frequency of obesity has increased worldwide,1 and 
studies have shown that excess body weight, manifested 
as a higher Body Mass Index (BMI), is associated with 
increased risk of thyroid cancer and other cancers in both 
genders.2-5 
Papillary thyroid carcinoma (PTC), the most common 
histologic type of thyroid malignancy, is also increasing 
globally.6 Although the reason for this rise in incidence are 
not clear, enhanced detection of early-stage tumors with 
the use of neck ultrasound and ultrasound-guided biopsy 
play a major role.7 
abstract
Background: Incidence of papillary thyroid carcinoma 
(PTC) and the frequency of obesity is increasing globally. 
In literature, relationship between excessive body weight 
and bad prognostic features of PTC is still debatable. In 
this study, we aimed to explore the association of obesity 
with high risk pathological features of PTC in a population 
treated by total thyroidectomy +/- neck dissection.
Materials and methods: Retrospective analysis 
of patients at Aga Khan University Hospital from 
January 2013 to December 2014, who underwent total 
thyroidectomy +/- neck dissection due to PTC. Patients 
were grouped according to World Health Organization 
(WHO) classification of BMI. They were categorized 
into two groups, i.e. normal (BMI= 18.5 - 24.9 kg/m2) 
and obese (BMI ≥ 30 kg/m2) as none of our patients lie 
in underweight and overweight category. Pathological 
features i.e. T-stage, multifocality, bilaterality, 
extrathyroidal extension, vascular invasion and N-stage 
were assessed. All tumors were staged according to 
TNM staging system proposed by 2010 American Joint 
Committee on Cancer (AJCC). Odds ratio (OR) with 95% 
confidence interval was used to examine the association 
between BMI & pathological characteristics of PTC.
results: A total of 53 patients were treated for PTC in 
two-years period. There were 38 female and 15 male 
patients. Twenty-eight patients had BMI in normal 
while twenty-five in obese category. Patients who were 
in obese category had a significantly greater risk of 
having a multifocal tumor (OR=5.55, p-value=0.02) and 
bilaterality (OR=6.54, p-value=0.01) compared to normal 
weight patients. No positive associations were identified 
between BMI and extrathyroidal extension, high T-stage, 
vascular invasion and N-stage.
Conclusion: Obesity is not associated with high risk 
pathological features such as extrathyroidal extention, 
high T-stage, vascular invasion and N-stage in PTC. 
Although it has been correlated with multifocal and 
bilateral tumors in this retrospective study, the presence 
of these factors alone is not adequate to support the 
association conclusively. 
Keywords: Papillary thyroid carcinoma, Body Mass 
Index, Pathological features, Total thyroidectomy, Obesity
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In literature, relationship between obesity and 
pathological features of PTC is indistinct. Less aggressive 
tumor features, such as the absence of nodal metastasis 
and tumor invasion was reported by Paes et al 8, while 
Kim et al 9 reported a positive association between obesity 
and advanced tumor stage.
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In this study, we aimed to explore the association of 
obesity with high risk pathological features of PTC in 
a population treated by total thyroidectomy +/- neck 
dissection. 
Materials and Methods
We retrospectively reviewed medical records and 
pathology reports of 101 consecutive patients with thyroid 
carcinoma at Aga Khan University Hospital from January 
2013 to December 2014. We excluded 48 patients with 
different histologic type than PTC. Thyroid function tests 
(serum TSH, free T3, and free T4) of all patients were 
preoperatively checked. We also collected medical history 
of diabetes mellitus, hypercholesterolemia, smoking and 
alcohol intake. A total of 53 cases were included in this 
study. Height and weight of each patient were recorded 
from preoperative anesthesia chart and by applying the 
formula of Body Mass Index (i.e., BMI = weight (kg) / 
height (m2)), BMI of each patient was calculated. We 
divided our cases according to World Health Organization 
(WHO) classification of BMI, i.e. underweight (<18.5 kg/
m2), normal (18.5 – 24.9 kg/m2), overweight (25-29.9 
kg/m2) and obese (≥30 kg/m2). None of our cases lie in 
underweight and overweight category so there were two 
groups in our study, i.e. normal and obese.
A standard operative procedure of total thyroidectomy 
+/- neck dissection was performed in all patients in our 
setting with pre-operative diagnosis of PTC by fine-
needle aspiration cytology(FNAC), even if the case falls in 
low risk category. Since there is no role of elective neck 
dissection in PTC, only therapeutic neck dissection in 
the form of either central, unilateral, bilateral or contra 
lateral was performed on the basis of positive neck node 
found pre-operatively through neck examination and/or 
imaging or intra-operatively through frozen section. All 
pathology specimens were reviewed by two experienced 
pathologists to confirm diagnosis, tumor characteristics 
and the extent of disease. All tumors were staged 
according to TNM staging system proposed by 2010 
American Joint Committee on Cancer (AJCC).10 As this 
was a retrospective study of routinely collected clinical 
data, patient consent was not required.
What are the high risk pathological features?
Features including higher T-stage (T3/T4) and 
N-stage (N1), bilaterality (tumor focus present in both 
lobes of thyroid), multifocality (more than one tumor focus 
present in either lobe of thyroid), distant metastasis, 
extrathyroidal extention and vascular invasion in final 
histopathology specimen are consider high risk as these 
factors are poor prognostic correlates11 and indicator 
for adjuvant radioactive iodine (RAI) therapy according 
to National Comprehensive Cancer Network (NCCN) 
guidelines version 2.2013.12
Statistical analysis
Patient data was compiled and analyzed using 
Statistical Package for Social Sciences (SPSS) Version 
21. Frequency and percentage were computed for 
categorical variables like gender, T-stage, multifocality, 
bilaterality, extrathyroidal extension, vascular invasion 
and N-stage. Mean ± SD was calculated for quantitative 
variables i.e. age, weight, height and Body Mass Index 
(BMI). Stratification was done on gender, age, T-stage, 
multifocality, bilaterality, extrathyroidal extension, vascular 
invasion and N-stage to see the effect of these modifiers 
on obesity using Chi-square test and Fisher’s exact test 
and p-value ≤0.05 was considered as significant.
Association between obesity and the pathological 
characteristics of PTC, as expressed in terms of odds ratio 
(OR) with 95% confidence interval (CI). The pathological 
factors of   PTC were treated as binary variables: 
extrathyroidal extention (present or absent), multifocality 
(present or absent), T stage (T1/T2 or T3/T4), bilaterality 
(present or absent), N-stage (N0 or N1) and vascular 
invasion (present or absent).  All OR were adjusted for age 
and gender.
results
Baseline pathological characteristics 
in patients with PTC
Pathological features of patients with PTC are 
summarized in Table 1. Among 53 patients, 38 (71.7%) 
were female and 15 (28.3%) were male. The mean age 
was 44.6 ± 14.3 years (range, 12 to 80 years). Based 
on WHO classification, there were 28(52.8%) normal and 
25(47.1%) obese patients. Two (3.7%) subjects in normal 
and  three (5.6%) in obese category had known history 
of diabetes mellitus, hypercholesterolemia and smoking. 
Similarly, three (5.6%) cases in each group had thyroid 
dysfunction which was preoperatively corrected. None 
of our patients had history of alcohol intake. Forty-three 
percent tumors had higher T-stage i.e. T3 and T4 while 
more than 10% cases had multifocal and bilateral PTCs 
along with extrathyroidal extention in final pathology 
specimens. Vascular invasion was found in 10(18.9%) 
cases while neck node metastasis was present in more 
than 40%. Only 2 cases (3.7%) with BMI in obese group 
had distant metastasis to lungs at the time of initial 
presentation. 
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weight and risk of developing thyroid and other types of 
cancer.2-5 In a study done by Sung et al. 16, greater the 
height, higher the chances of developing thyroid cancer in 
both genders. Previous studies exploring the associations 
between obesity and pathological features of PTC 
reported inconsistent results. Study from South Korea9 
showed a favorable relation between obesity and tumor 
stage, even though the association was not statistically 
significant. On the other hand, research from Ohio State 
University Medical Center8 reported lower risk of tumor 
invasiveness & nodal metastasis with excessive BMI. Our 
study also showed no association between obesity & poor 
pathological features namely extrathyroidal extension, 
vascular invasion, tumor size and cervical metastasis. 
Unlike Kim et al.11, which described strong relationship 
of higher BMI with large tumor size, microscopic 
extrathyroidal invasion and advanced tumor-node-
metastasis stage, our study showed positive link with 
only multifocal and bilateral tumors. There have been 
number of prior studies about the origin of multifocal and 
bilateral PTC foci with evidence supporting two opinions, 
i.e., de novo carcinogenesis or intrathyroidal metastasis. 
But why multifocal and bilateral tumor foci had favorable 
association with obesity, we unable to explain. Similarly, 
the negative connection between elevated weight, 
pathological features of tumor and clinical course is 
unknown. One explanation for this when compared to 
breast cancer in which obesity has strong relationship 
with poor clinical behavior of tumor is that the amount 
of adipose tissue in the thyroid is significantly lesser than 
breast tissue. This cancer-adipocyte interaction may be 
the cause of difference in behavior in these two types of 
malignancy. Furthermore, certain cytokines such as leptin 
released from fat cells are also involved on thyroid cancer 
progression.17 Prior researches reported high blood 
levels of leptin along-with expression of its receptor in 
patients with PTC. Akinci et al.18 and Cheng et al. 19 also 
described this leptin-tumor aggressiveness correlation 
in their published papers. Conversely, adiponectin levels 
were shown to be negatively associated with body fat and 
BMI 17 and circulating adiponectin was inversely linked 
with the risk of thyroid cancer.20 Additional researches 
required to find out the potential mechanisms underlying 
the interaction between obesity and high risk features in 
papillary thyroid cancer.
In the future, we are planning to follow these cases for 
longer duration to detect whether this positive or negative 
association of obesity with high risk pathological features 
has impact on tumor recurrence or not. 
The limitations of our study was its retrospective 
nature, small sample size and lack of information 
regarding physical activity. We only selected patients 
Table 1: Baseline characteristics of patients with papillary 
thyroid carcinoma (PTC)
Acronyms: n = number of cases; BMI = body mass index; T 
stage = tumor stage; N stage = nodal stage
associations between BMi and pathological 
features of PTC
Patients who were obese had a significantly greater 
risk of having a multifocal tumor (OR=5.55, p-value=0.02) 
and bilaterality (OR=6.54, p-value=0.01) compared to 
normal. Cases in obese group also had higher frequencies 
of advanced T-stage and N-stage tumors along with 
lesions having extrathyroidal extention and vascular 
invasion, but it was not statistically significant (Table 2).
discussion
In literature many studies on the correlations between 
thyroid cancer, specifically papillary thyroid carcinoma 
and obesity have been published.13-16 However there 
were variations that exists in majority of studies due to 
which there is no definite conclusion on the association 
between obesity and thyroid malignancy. According to 
Renehan et al. 4, higher incidence of thyroid malignancy 
has been associated with increased BMI. Other works 
also suggested positive link between excessive body 
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Table 2.  association of BMi and pathological features in patients with PTC
Acronyms: n = number of cases; BMI = body mass index; OR = odds ratio; CI = confidence interval; T stage = tumor stage; N stage 
= nodal stage
who underwent total thyroidectomy and not included 
those in which lobectomy was performed. Although BMI 
determinations have been the most commonly used 
assessment scale for obesity in the medical practice, 
but measurements such as waist circumference, neck 
circumference and skin-fold thickness may be better 
tools for this type of study.
Conclusion
In the end, we conclude that obesity is not associated 
with high risk pathological features such as extrathyroidal 
extention, high T-stage, vascular invasion and N-stage in 
PTC. Although it has been correlated with multifocal and 
bilateral tumors in this retrospective study, the presence 
of these factors alone is not adequate to support the 
association conclusively. Further corroborative studies to 
confirm these findings are essential.
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